COR · 8-K · 20260805PR000032

Revenue Performance and Mix

Cencora, Inc. · 2026-08-05 · Importance 49 · Surprise 32 · In source text

Third-quarter revenue increased 5.1% year over year to $84.8 billion for the quarter ended June 30, 2026. U.S. Healthcare Solutions revenue rose 4.9% to $74.9 billion, driven by unit-volume growth in specialty products and GLP-1 products, partially offset by lower manufacturer prices, the 2025 loss of an oncology customer, and lower sales to a large mail-order customer. International Healthcare Solutions revenue increased 5.9% to $7.7 billion, led by European distribution and global specialty logistics, while Other revenue increased 6.9% to $2.3 billion, driven by Profarma and MWI Animal Health growth and partially offset by the U.S. Consulting Services divestiture.

Key facts

• Revenue for the third quarter of fiscal 2026: $84.8 billion, a 5.1 percent increase year-over-year source
• U.S. Healthcare Solutions segment revenue in third quarter fiscal 2026: $74.9 billion, up 4.9% year-over-year source
• International Healthcare Solutions segment revenue in third quarter fiscal 2026: $7.7 billion, up 5.9% year-over-year source
• Other segment revenue in third quarter fiscal 2026: $2.3 billion, up 6.9% year-over-year source
• Constant currency $7.7B source
• Constant currency $169M source
• $7.7B source
• $166M source

Impact estimates